Health & Beauty

Liverpool researchers find treatment for ultra-rare disease

The FINANCIAL -- A new study published in Molecular Genetics and Metabolism, conducted by a Liverpool based research collaboration involving the University of Liverpool, has identified the drug that treats the extremely rare genetic disease alkaptonuria ...

Roche reports very strong performance in the first half of 2018

The FINANCIAL -- Group sales increase 7%1 at constant exchange rates and in Swiss ...

Gilead Sciences Announces Second Quarter 2018 Financial Results

The FINANCIAL -- FOSTER CITY, Calif -- Jul. 25, 2018-- Gilead Sciences, Inc. announced its results of operations for the second quarter ended June 30, 2018. The financial results that follow ...

AbbVie Receives U.S. FDA Approval of ORILISSA

The FINANCIAL -- ORILISSA (elagolix) is the first FDA-approved oral treatment for the management of moderate to severe pain associated with endometriosis in over a ...

Ebola outbreak in DRC ends

The FINANCIAL -- The end of the ninth outbreak of Ebola in the Democratic Republic of the Congo (DRC) is marked. The World Health Organization (WHO) congratulates the country and all those involved ...

Amgen Breaks Ground On Next-Generation Biomanufacturing Plant In Rhode Island

The FINANCIAL -- Amgen announced the groundbreaking of its new next-generation biomanufacturing plant that will be constructed at its West Greenwich, R.I. campus. The new plant is the ...

Cluster of presumptive Ebola cases in North Kivu in the Democratic Republic of the Congo

The FINANCIAL -- The Government of the Democratic Republic of the Congo announced today that preliminary laboratory results indicate a cluster of cases of Ebola virus in North Kivu province. The ...

Novartis marks a new era for migraine patients

The FINANCIAL -- Patients on Aimovig (erenumab) in clinical trials reported consistent and sustained migraine prevention, with many experiencing a 50% or more reduction in monthly migraine days; ...